u/karl_fischer_kev

Started weighing protein rather than estimating it. The gap between what I thought and what I ate was embarrassing.

DEXA has a meaningful coefficient of variation, and it differs between machines and protocols. Comparing scans from different clinics adds a systematic offset that is invisible on the report.

keep the hash, it is the only receipt that exists

10mg into 1mL is 10mg/mL, and 1.5mg of that is 15 units

the same token exists on several chains and they are not interchangeable

Lost slower for six months deliberately and my composition change was not obviously different. Training was what mattered.

Some lean mass loss accompanies weight loss in any deficit. Resistance training and adequate protein intake are the two interventions with the best evidence for limiting the proportion.

The lyophilised cake displaces a small volume, so the true concentration is very slightly lower than the arithmetic suggests. It is a fraction of a percent and it is dwarfed by fill tolerance.

That comparison crosses two labs with different assays. The difference you are describing may be the method.

Cosigning that protein gets harder precisely when appetite drops. That is the actual difficulty and it is logistical.

How to make a panel worth comparing, which is most of the value people leave on the table.

Standardise the conditions: same lab, same fasting state, same rough time of day, same point in the week, similar hydration. Take a baseline before you change anything. Repeat any surprising value before acting on it. Change one thing at a time if you want to attribute anything to it.

Do that and a year of panels is a trend. Skip it and a year of panels is a collection of unrelated mornings, which is what most of the alarmed posts here are actually describing.

The confounding problem, stated plainly, because this board keeps stepping on it.

Substantial weight loss moves lipids, liver enzymes, insulin sensitivity markers and several others in its own right. If you are losing weight while taking something, any change in those markers has at least two candidate explanations and you cannot separate them from your own panel.

What you can do is standardise, take a baseline, keep the series long, and be honest in your posts about what is and is not attributable. The threads that say "this compound did X to my TSH" almost never have the design to support the claim, mine included.

DEXA has a meaningful coefficient of variation, and it differs between machines and protocols. Comparing scans from different clinics adds a systematic offset that is invisible on the report.

Cardiovascular outcome trials are powered for events, not for weight, and are typically run in a different population with different inclusion criteria. Reading a weight number out of one is reading a secondary endpoint.

The whole calculation, once, with real numbers.

You have a 5mg vial. You add 3mL of bacteriostatic water. Concentration is mass over volume: 1.67mg/mL. A U-100 insulin syringe is graduated at 100 units per millilitre, so one unit is 0.01mL.

To draw 1.5mg you need 1.5 divided by 1.67 millilitres, which is 90 units on the barrel. Write "1.67mg/mL" on the vial in marker before you put it away, and you never have to do this again for that vial.

Not convinced by the attribution. That pattern tracks the cycle in your own log more closely than it tracks the dose.

phase 2 finds a dose, phase 3 measures the effect

Discontinuation rates are a tolerability result. A trial with a strong efficacy number and heavy discontinuation is telling you two things and people only quote one.

Wrote the concentration into the log as well as on the vial. Have referred back to it more than once.

Are the missed weeks in there as blanks or dropped entirely?

This. Intention-to-treat versus completer analysis routinely moves the headline by several points.

That only works if the fill weight is exactly the label weight, and it usually is not exactly anything.

Rate quotes expire because the underlying rate moves. A short expiry is ordinary; urgency about your decision is a separate signal and should be read separately.

check who the comparator was before you compare anything

trial populations get support that nobody on this board gets

lean mass loss during weight loss is expected, the question is how much

Small fix — insulin resistance is a feature commonly seen in PCOS, not a synonym for it.

Bacteriostatic water contains benzyl alcohol as a preservative, which is what makes repeated entry into the same vial reasonable. Plain sterile water has no preservative.

Agreed — units are volume. Once that lands, the rest of the arithmetic is one division.

Which networks did they list as accepted?

I would not read one person’s cycle-linked experience as a general pattern. The variation here is enormous.

Right — strength retention is a free proxy and it tracks better than most people expect.

Fat-free mass index is a ratio of fat-free mass to height squared. It moves when either term does, which makes it awkward to interpret during active weight change.

Yes. Repeat before you react. Almost every alarming single value I have posted here regressed on the repeat.

Memo requirements are chain-specific. The chain you are describing does not use one.

grip strength and lift numbers are cheap longitudinal markers

fertility can change with weight loss and that surprises people

What was the discontinuation rate?

Not convinced by the attribution. Weight loss alone moves that marker and you have no way to separate the two.

dead space in the needle hub is real and it is small